|Salary:||£26,829 to £31,076|
|Contract Type:||Contract / Temporary|
|Placed on:||9th January 2017|
|Closes:||19th January 2017|
Department: Lancaster Medical School
This post is full-time, fixed term for 12 months, with the possibility of extension subject to availability of funding.
You will join Lancaster Medical School to work with Dr Jemma Kerns for the delivery of a new 3D tool upon which to grow and monitor the response of primary bone cells to treatment, for use to directly improve patient outcomes.
This device, coupled with Raman spectroscopy will significantly contribute to managing healthcare costs and reducing the burden of disease from osteoporosis in an ageing population. It will allow for the optimal treatment to be determined in a shorter time-frame and provide a platform for future drug testing, without the need for animal testing.
This project is funded by an InnovateUK feasibility grant in collaboration with ReVivoCell Limited, an SME based in the North West of England.
You will join a top 10-UK university with excellent laboratory facilities and situated in a vibrant research environment. During the project you will also have the opportunity to engage with a world-leading consortium of bone researchers at University College London (Prof Goodship, Prof Birch), Royal National Orthopaedic Hospital, Stanmore and Prof Parker and Prof Matousek at the Rutherford Appleton Laboratory, STFC, Oxford.
Interview Date: 26 January 2017
For more information please contact Dr Jemma Kerns, email@example.com
We welcome applications from people in all diversity groups.
Share this job
Type / Role: